Vsv Moldes

Vsv Moldes company information, Employees & Contact Information

Explore related pages

Related company profiles:

Since 2001, VSV MOLDES has established itself in the market as a reference in the mold making industry. With the experience gained over the years, VSV MOLDES held a special attention to technological evolution, resulting in a major positive impact and a large growth in the activity. VSV MOLDES have a specialized team and updated technology that meet the demands of the market.

Company Details

Employees
17
Founded
-
Address
Avenida Nossa Senhora Da Nazaré 70, Martingança,leiria 2445-047,portugal
Industry
Plastics Manufacturing
NAICS
Plastics Product Manufacturing
Plastics Packaging Materials and Unlaminated Film and Sheet Manufacturing
Plastics Pipe, Pipe Fitting, and Unlaminated Profile Shape Manufacturing
Laminated Plastics Plate, Sheet (except Packaging), and Shape Manufacturing
Polystyrene Foam Product Manufacturing
Urethane and Other Foam Product (except Polystyrene) Manufacturing
Plastics Bottle Manufacturing
Other Plastics Product Manufacturing
Plastics Bag and Pouch Manufacturing
Unlaminated Plastics Film and Sheet (except Packaging) Manufacturing
Unlaminated Plastics Profile Shape Manufacturing
Plastics Pipe and Pipe Fitting Manufacturing
Plastics Plumbing Fixture Manufacturing
All Other Plastics Product Manufacturing
Website
vsv.pt
HQ
Martingança, Leiria
Looking for a particular Vsv Moldes employee's phone or email?

Vsv Moldes Questions

News

Single dose VSV-based vaccine protects mice against lethal heterologous Crimean-Congo hemorrhagic fever virus challenge - Nature

Single dose VSV-based vaccine protects mice against lethal heterologous Crimean-Congo hemorrhagic fever virus challenge Nature

Single-Dose VSV Vaccine Fully Protects Mice Against Crimean-Congo Hemorrhagic Fever - Global Biodefense

Single-Dose VSV Vaccine Fully Protects Mice Against Crimean-Congo Hemorrhagic Fever Global Biodefense

Final call! Clear your tax disputes under VSV 2.0: Here's how - Business Standard

Final call! Clear your tax disputes under VSV 2.0: Here's how Business Standard

Repeated harvest enables efficient production of VSV-GP - Frontiers

Repeated harvest enables efficient production of VSV-GP Frontiers

T cell-mediated tumour regression through infection of both cancer and non-cancer cells - Nature

T cell-mediated tumour regression through infection of both cancer and non-cancer cells Nature

Transcriptome analysis of long non-coding RNA and mRNA Profiles in VSV-infected BHK-21 Cells - BMC Genomics

Transcriptome analysis of long non-coding RNA and mRNA Profiles in VSV-infected BHK-21 Cells BMC Genomics

Replication-incompetent VSV-based vaccine elicits protective responses against SARS-CoV-2 and influenza virus - Science | AAAS

Replication-incompetent VSV-based vaccine elicits protective responses against SARS-CoV-2 and influenza virus Science | AAAS

Translational success of fundamental virology: a VSV-vectored Ebola vaccine - ASM Journals

Translational success of fundamental virology: a VSV-vectored Ebola vaccine ASM Journals

Vesicular Stomatitis Virus (VSV) case confirmed in Oklahoma - Oklahoma State University

Vesicular Stomatitis Virus (VSV) case confirmed in Oklahoma Oklahoma State University

Preclinical efficacy of oncolytic VSV-IFNβ in treating cancer: A systematic review - Frontiers

Preclinical efficacy of oncolytic VSV-IFNβ in treating cancer: A systematic review Frontiers

Improved thermal stabilization of VSV-vector with enhanced vacuum drying in pullulan and trehalose-based films - Nature

Improved thermal stabilization of VSV-vector with enhanced vacuum drying in pullulan and trehalose-based films Nature

Perfusion process with tangential flow filtration for oncolytic VSV-GP production - Frontiers

Perfusion process with tangential flow filtration for oncolytic VSV-GP production Frontiers

Single dose recombinant VSV based vaccine elicits robust and durable neutralizing antibody against Hantaan virus - Nature

Single dose recombinant VSV based vaccine elicits robust and durable neutralizing antibody against Hantaan virus Nature

Repurposing the oncolytic virus VSV∆51M as a COVID-19 vaccine - Frontiers

Repurposing the oncolytic virus VSV∆51M as a COVID-19 vaccine Frontiers

SARS-CoV-2 inhibition and specific targeting of infected cells by VSV particles carrying the ACE2 receptor - Nature

SARS-CoV-2 inhibition and specific targeting of infected cells by VSV particles carrying the ACE2 receptor Nature

Protection from COVID-19 with a VSV-based vaccine expressing the spike and nucleocapsid proteins - Frontiers

Protection from COVID-19 with a VSV-based vaccine expressing the spike and nucleocapsid proteins Frontiers

Effectiveness of VSV vectored SARS-CoV-2 spike when administered through intranasal, intramuscular or a combination of both - Nature

Effectiveness of VSV vectored SARS-CoV-2 spike when administered through intranasal, intramuscular or a combination of both Nature

Development and Applications of VSV Vectors Based on Cell Tropism - Frontiers

Development and Applications of VSV Vectors Based on Cell Tropism Frontiers

Optimized intramuscular immunization with VSV-vectored spike protein triggers a superior immune response to SARS-CoV-2 - Nature

Optimized intramuscular immunization with VSV-vectored spike protein triggers a superior immune response to SARS-CoV-2 Nature

A VSV-based assay quantifies coronavirus Mpro/3CLpro/Nsp5 main protease activity and chemical inhibition - Nature

A VSV-based assay quantifies coronavirus Mpro/3CLpro/Nsp5 main protease activity and chemical inhibition Nature

A single dose of recombinant VSV-∆G-spike vaccine provides protection against SARS-CoV-2 challenge - Nature

A single dose of recombinant VSV-∆G-spike vaccine provides protection against SARS-CoV-2 challenge Nature

Oncolytic virotherapy induced CSDE1 neo-antigenesis restricts VSV replication but can be targeted by immunotherapy - Nature

Oncolytic virotherapy induced CSDE1 neo-antigenesis restricts VSV replication but can be targeted by immunotherapy Nature

Enhanced protective immunity against SARS-CoV-2 elicited by a VSV vector expressing a chimeric spike protein - Nature

Enhanced protective immunity against SARS-CoV-2 elicited by a VSV vector expressing a chimeric spike protein Nature

Structural basis for the recognition of LDL-receptor family members by VSV glycoprotein - Nature

Structural basis for the recognition of LDL-receptor family members by VSV glycoprotein Nature

The lytic activity of VSV-GP treatment dominates the therapeutic effects in a syngeneic model of lung cancer - Nature

The lytic activity of VSV-GP treatment dominates the therapeutic effects in a syngeneic model of lung cancer Nature

Identification of a pH-Sensitive Switch in VSV-G and a Crystal Structure of the G Pre-fusion State Highlight the VSV-G Structural Transition Pathway - ScienceDirect.com

Identification of a pH-Sensitive Switch in VSV-G and a Crystal Structure of the G Pre-fusion State Highlight the VSV-G Structural Transition Pathway ScienceDirect.com

Neutralizing Antibody and Soluble ACE2 Inhibition of a Replication-Competent VSV-SARS-CoV-2 and a Clinical Isolate of SARS-CoV-2 - ScienceDirect.com

Neutralizing Antibody and Soluble ACE2 Inhibition of a Replication-Competent VSV-SARS-CoV-2 and a Clinical Isolate of SARS-CoV-2 ScienceDirect.com

Single-dose VSV-based vaccine protects cynomolgus macaques from disease after Taï Forest virus infection - Taylor & Francis Online

Single-dose VSV-based vaccine protects cynomolgus macaques from disease after Taï Forest virus infection Taylor & Francis Online

VSV-GP: a Potent Viral Vaccine Vector That Boosts the Immune Response upon Repeated Applications - ASM Journals

VSV-GP: a Potent Viral Vaccine Vector That Boosts the Immune Response upon Repeated Applications ASM Journals

A VSV-based Zika virus vaccine protects mice from lethal challenge - Scientific Reports - Nature

A VSV-based Zika virus vaccine protects mice from lethal challenge - Scientific Reports Nature

Engineering lentivirus envelope VSV-G for liver targeted delivery of IDOL-shRNA to ameliorate hypercholesterolemia and atherosclerosis - ScienceDirect.com

Engineering lentivirus envelope VSV-G for liver targeted delivery of IDOL-shRNA to ameliorate hypercholesterolemia and atherosclerosis ScienceDirect.com

YAP1 nuclear efflux and transcriptional reprograming follow membrane diminution upon VSV-G-induced cell fusion - Nature

YAP1 nuclear efflux and transcriptional reprograming follow membrane diminution upon VSV-G-induced cell fusion Nature

Pseudotyping of VSV with Ebola virus glycoprotein is superior to HIV-1 for the assessment of neutralising antibodies - Nature

Pseudotyping of VSV with Ebola virus glycoprotein is superior to HIV-1 for the assessment of neutralising antibodies Nature

A time-resolved molecular map of the macrophage response to VSV infection | npj Systems Biology and Applications - Nature

A time-resolved molecular map of the macrophage response to VSV infection | npj Systems Biology and Applications Nature

A VSV-based COVID vaccine effective against SARS-CoV-2 variants - News-Medical

A VSV-based COVID vaccine effective against SARS-CoV-2 variants News-Medical

Spray dried VSV-vectored vaccine is thermally stable and immunologically active in vivo - Nature

Spray dried VSV-vectored vaccine is thermally stable and immunologically active in vivo Nature

Baicalein inhibits SARS-CoV-2/VSV replication with interfering mitochondrial oxidative phosphorylation in a mPTP dependent manner | Signal Transduction and Targeted Therapy - Nature

Baicalein inhibits SARS-CoV-2/VSV replication with interfering mitochondrial oxidative phosphorylation in a mPTP dependent manner | Signal Transduction and Targeted Therapy Nature

Turn Therapeutics Announces Vaccine Breakthrough: Validates 100% VSV Recovery from Petrolatum Carrier at 24 and 72 Hours - Business Wire

Turn Therapeutics Announces Vaccine Breakthrough: Validates 100% VSV Recovery from Petrolatum Carrier at 24 and 72 Hours Business Wire

Distinct VSV-based Nipah virus vaccines expressing either glycoprotein G or fusion protein F provide homologous and heterologous protection in a nonhuman primate model - eBioMedicine - The Lancet

Distinct VSV-based Nipah virus vaccines expressing either glycoprotein G or fusion protein F provide homologous and heterologous protection in a nonhuman primate model - eBioMedicine The Lancet

Analysis of VSV pseudotype virus infection mediated by rubella virus envelope proteins - Nature

Analysis of VSV pseudotype virus infection mediated by rubella virus envelope proteins Nature

Meningeal myeloma deposits adversely impact the therapeutic index of an oncolytic VSV - Nature

Meningeal myeloma deposits adversely impact the therapeutic index of an oncolytic VSV Nature

VSV Confirmed in Two Newly Infected Kansas Counties - thehorse.com

VSV Confirmed in Two Newly Infected Kansas Counties thehorse.com

VSV DISEASE CONFIRMED IN RHINOS AT SAN DIEGO ZOO SAFARI PARK - East County Magazine

VSV DISEASE CONFIRMED IN RHINOS AT SAN DIEGO ZOO SAFARI PARK East County Magazine

Horses From VSV-Affected Areas Banned From American Quarter Horse Congress - thehorse.com

Horses From VSV-Affected Areas Banned From American Quarter Horse Congress thehorse.com

Arizona Horse Confirmed With VSV - thehorse.com

Arizona Horse Confirmed With VSV thehorse.com

Dr. V.S.V. "Raj" Rajan - Legacy obituary

Dr. V.S.V. "Raj" Rajan Legacy obituary

Fisk Seafood acquires one-third of VSV - SeafoodSource

Fisk Seafood acquires one-third of VSV SeafoodSource

Protein Transfer Into Human Cells by VSV-G-induced Nanovesicles - ScienceDirect.com

Protein Transfer Into Human Cells by VSV-G-induced Nanovesicles ScienceDirect.com

1995. VSV 50: the Concorde of the sea - Barche a Motore

1995. VSV 50: the Concorde of the sea Barche a Motore

VSV Mary Slim cruises Portland to Rockall in 53 hours - Motor Boat & Yachting

VSV Mary Slim cruises Portland to Rockall in 53 hours Motor Boat & Yachting

VsV scheme: I-T dept extends deadline to avail interest, penalty waiver till Jan 31 - Zee Business

VsV scheme: I-T dept extends deadline to avail interest, penalty waiver till Jan 31 Zee Business

Bombay High Court Extends VSV Scheme to Reclassified Medium Enterprises - KNN India

Bombay High Court Extends VSV Scheme to Reclassified Medium Enterprises KNN India

No need for Form 26B Once Form 5 issued under VSV Act: Allahabad HC directs ₹2.19 Cr Refund to Dish TV [Read Order] - Taxscan

No need for Form 26B Once Form 5 issued under VSV Act: Allahabad HC directs ₹2.19 Cr Refund to Dish TV [Read Order] Taxscan

About Vivad Se Vishwas Scheme 2024 (VSV 2.0): - Vajiram & Ravi

About Vivad Se Vishwas Scheme 2024 (VSV 2.0): Vajiram & Ravi

Top Vsv Moldes Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant